Stay up-to-date with our latest news

Wonderful first day at PBC Group - Organisers of the COG Series in Amsterdam! Wonderful to catch up with familiar faces as well to make new friends! 🥳 Happy to represent Ad Hoc Clinical here! 🧩 hashtag#ClinicalTrials hashtag#Investigations hashtag#Collaborations hashtag#Research

Next stop: Amsterdam! On 15–16 September, I’ll be at the COG CRO Summit Europe, ready for fresh perspectives on clinical research, meaningful collaborations, innovation & AI, ... And yes… I’m hoping to come back with more insights than screenshots of presentation slides😄📸 If you’re there too, I'm already looking forward (re)connecting! 👋 PBC Group - Organisers of the COG Series hashtag#COG hashtag#AHC hashtag#ClinicalResearch hashtag#Amsterdam hashtag#LifeSciences

🥳 Incredible milestones at Ad Hoc Clinical 🥳 A huge thank you to Joyce for 𝟙𝟘 𝕪𝕖𝕒𝕣𝕤 of dedication, commitment and your inspiring can-do attitude. Your passion, eye for quality and exceptional expertise have made a real difference every single day. We are incredibly proud to have you as part of our team and truly grateful for everything you've contributed over the past decade. Here's to celebrating this amazing achievement, and to many more great years together. Congr

Sweet moments, strong team 🍫🏁 At Ad Hoc Clinical, we don't just navigate clinical research, we apparently navigate rally routes too! Add some chocolate, sunshine, and great colleagues, and you've got the recipe for a perfect teambuilding! 🍫🏁☀️ #TeamBuilding #StrongerTogether #TeamSpirit #SweetMomentsStrongTeam

On the 17th of June 2026, the BioWin team had all the ingredients for an inspiring evening:a beautiful château, inspiring people, meaningful connections, and enough innovation in one room to power a small country! Cheers to BioWin for a fantastic Annual Dinner and for bringing together such a wonderful group of people under one roof! Thank you, and see you next year!

Clinical trials continue evolving, and so does ICH GCP E6(R3)! Annex 2 is catching up with reality. The finalization of Annex 2 acknowledges what many of us in clinical research have already been doing: more decentralized approaches, digital tools, and real-world data being integrated into clinical research. Annex 2 provides additional guidance on how innovation and participant protection can continue to go hand in hand. Some notable developments include: 🟠 Continued focus o